Several phenyl substituted naphthalenes and isoquinolines have been identified as antibacterial agents that inhibit FtsZ-Zing formation. In the present study we evaluated the antibacterial of several phenyl substituted quinoxalines, quinazolines and 1,5-naphthyridines against methicillin-sensitive and methicillin-resistant Staphylococcus aureus and vancomycin-sensitive and vancomycin-resistant Enterococcus faecalis. Some of the more active compounds against S. aureus were evaluated for their effect on FtsZ protein polymerization. Further studies were also performed to assess their relative bactericidal and bacteriostatic activities. The notable differences observed between nonquaternized and quaternized quinoxaline derivatives suggest that differing mechanisms of action are associated with their antibacterial properties.
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Nosocomial infections associated with multidrug-resistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) represent a major public health concern. [1] [2] [3] [4] Increased bacterial resistance to conventional antibiotics has brought attention to the critical need for the identification of novel therapeutic antibacterial targets. 5 FtsZ is an essential and highly conserved bacterial protein involved in cytokinesis. [6] [7] [8] [9] Cell division in bacteria occurs at the site of formation of a cytokinetic Z-ring polymeric structure comprised of FtsZ subunits. FtsZ forms the Z-ring via a process of GTP-dependent self-polymerization. [7] [8] [9] The Z-ring plays a key role in constriction of the bacterial cell wall and serves as a scaffold for the recruitment of other components of the cell division machinery. 7, 9 Several recent reviews have discussed the potential of antibacterial agents that target FtsZ, as well as recent advances in the discovery of small molecules that perturb processes in which FtsZ is involved. [10] [11] [12] [13] [14] [15] FtsZ-targeting antibacterial agents can exert their disruptive effects on the Z-ring by either enhancing or inhibiting FtsZ self-polymerization. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Several phenyl substituted naphthalenes and isoquinolines were identified as antibacterial agents that act as stimulators of FtsZ polymerization. [26] [27] [28] In the present study, we evaluated of the bactericidal and bacteriostatic potential of phenyl substituted quinoxalines, quinazolines and 1,5-naphthyridines and examined their effect on FtsZ protein polymerization. The quinoxaline derivatives evaluated in this study are listed in Table 1 . Commercially available quinoxaline 1 was converted to 1-methylquinoxalinium iodide 2 by treatment with methyl iodide at 80°C in a sealed vial. The 2-substituted quinoxalines 2a-10a and the N-methylated derivatives 2b-9b were prepared as outlined in Scheme 1. 2-Trifluoromethylsulfonyloxyquinoxaline was prepared as previously described. 29 For the preparation of 7a, 3-(t-butyl)-5-(carbomethoxy)phenylboronic acid pinacol ester was used in the Suzuki coupling. This boronate ester was prepared by treating commercially available methyl 3-bromo-5-iodobenzoate with 4-t-butylphenylboronic acid in the presence of Pd(PPh 3 ) 4 .
The resulting 3-bromo-5-carbomethoxy-4 0 -(t-butyl)biphenyl was converted to it's pinacol ester by standard coupling conditions using bis(pinacolato)diboron and PdCl 2 (dppf) with KOAc in dioxane.
The assignment of the site of N-methylation in the case of 2b-9b is based upon the literature [30] [31] [32] [33] and spectral data from chloroquinoxalines was then subester by standard coupling conditions usingbisjected to Suzuki coupling conditions using either 3-t-butylphenylboronic acid or 4-t-butylphenylboronic acid. Isolated from the mixture formed in each instance was 2-(3-tbutylphenyl)-6-methylquinoxaline and 2-(4-t-butylphenyl)-5-methylquinoxaline, respectively. Each of the isolated 5-methylquinoxalines were treated with NBS to form their bromomethyl derivatives, which subsequently was converted to their respective guanidinomethyl derivatives, 11a and 12a. The spectral identification of the 2-phenyl-6-methylquinoxaline was based on a careful analysis of 2D-NOESY and gCOSY spectral data. The position of the phenyl moiety was established unequivocally on the basis of detailed gHMQC and gHMBC spectral analyses, which are detailed in the Supporting information.
The quinazoline and 1,5-naphthyridines synthesized and evaluated for antibacterial activity are listed in Table 2 . The substituted 4-phenylquinazoline derivatives 13 and 14 were synthesized as outlined in Scheme 3. 4-Chloro-8-methylquinazoline was prepared as described in the literature. 35 Suzuki coupling of this intermediate using 4-t-butylphenylboronic acid provided 4-(4-t-butylphenyl)-8-methylquinazoline. Treatment of this intermediate with NBS provided the bromomethyl derivative, which was converted to its azide derivative and subsequently reduced to provide the aminomethyl derivative 13. Alternative, this bromomethylquinazoline could be treated with 1,3-bis(t-butoxycarbonyl)guanidine and the N-Boc protecting groups removed using trifluoroacetic acid in dichloromethane. Compound 16 was prepared as shown in Scheme 4. Conversion of 4-methyl-8-hydroxyquinazoline to its triflate and subsequent Suzuki coupling using 4-t-butylphenylboronic acid gave 3-methyl-8-(4-t-butylphenyl)quinazoline. This intermediate was converted to its bromomethyl derivative using NBS in CCl 4 . Using conditions as previously described for 4-(4-t-butylphenyl)-8-bromomethylquinazoline, this bromomethyl derivative could be converted to its guanidinomethyl derivative 16.
The synthesis of the naphthyridine derivatives 17 and 18 was accomplished as outlined in Scheme 5. Conversion of 4-hydroxy-8-methyl [1, 5] naphthyridine to its triflate, followed by Suzuki coupling with 4-t-butylphenylboronic acid provided 4-(4-t-butylphenyl)-8-methyl [1, 5] naphthyridine. The methyl substituent could be converted to its aminomethyl derivative 17 or its guanidinomethyl derivative 18 using methodology previously described in this study for methylquinazolines.
The relative antibacterial activities of these varied quinoxalines and methylquinoxalinium derivatives against methicillin-sensitive S. aureus (MSSA), methicilllin-resistant S. aureus (MRSA), vancomycin-sensitive Entercoccus faecalis (VSE) and vancomycin-resistant E. faecalis (VRE) are provided in Table3. Quinoxaline and N-methylquinoxalinium iodide did not exhibit notable antibacterial activity against S. aureus or E. faecalis. The presence of hydrophoblic moieties such as a phenyl, 4-fluorophenyl, 3-biphenyl, or 4-t-butylphenyl at the 3-position of 1-methylquinoxalinium iodides 2b-6b, but not at the 2-position of quinoxaline (2a-6a), resulted in a significant increase in antibacterial activity. A similar trend was observed for quinoxalines structurally-related to 6a and 6b, having a 5-carboxymethy substituent (7a and 7b), a 5-carboxyamido substituent (8a and 8b) or a 5-carboxamido-N-(2-hydroxyethyl) group (9a and 9b). Only in the case of the related carboxamido derivative with an N-(2-aminoethyl) substituent (10a) was significant activity observed for a quinoxaline derivative. The placement of a guanidinomethyl substituent at the 5-position of either a 2-(3-t-butylphenyl)quinoxaline or 2-(4-t-butylphenyl)quinoxaline (11a and 12a) did result in a notable increase in antibacterial activity.
These data tend to suggest that these highly basic substituents that would be protonated at physiological pH could mimic the charge associated with the analogous 1-methylquioxalinium derivatives 5b and 6b. Other diazanaphthalenes were examined including the quinazolines 13-16 and 1,5-naphthyridine derivatives (17 and 18) . In both instances, the less basic aminomethyl derivatives (13 and 17) did not exhibit significant antibacterial activity. While the amidinomethyl derivative (15) did not exhibit significant activity, in the case of the guanidinomethyl derivatives (14 and 18) more pronounced antibacterial activity was observed. Alternating position of the t-butylphenyl substituent and the guanidinomethyl The antibacterial activities of the more potent quinoxaline (4b, 5b, 6b, 11a, and 12a), quinazoline (14) , and 1,5-naphthyridine (18) compounds prompted further investigation as to whether these activities are bactericidal or bacteriostatic in nature. In this connection, values of minimal bactericidal concentration (MBC) for these select compounds in S. aureus 8325-4 (MSSA), S. aureus ATCC 33591 (MRSA), and E. faecalis ATCC 51575 (VRE) were determined and subsequently compared with the corresponding MIC values listed in Table 3 . For these determinations, the bactericidal drug vancomycin 37 and the bacteriostatic drug erythromycin 38 were used as comparator controls. Per CLSI guidelines, an MBC/MIC ratio of 1-2 is considered indicative of bactericidal behavior, with a corresponding MBC/MIC ratio P8 being considered indicative of bacteriostatic behavior. 36 The comparator control agents yielded expected results, with an MIC/MBC ratio of 1 being observed for the bactericidal drug vancomycin and an MBC/MIC ratio of 256 being observed for the bacteriostatic drug erythromycin (see Table 4 ). The nonquaternary quinoxaline (11a and 12a), quinazoline (14) , and 1,5-naphthyridine (18) compounds were all associated with an MBC/MIC ratio of 1-2, indicative of a bactericidal mode of action against MSSA, MRSA, and VRE. In striking contrast to the nonquaternary compounds, the quaternary quinoxaline compounds 4b, 5b, and 6b were associated with MBC/MIC ratios of 8-16 for MSSA and MRSA and 4-8 for VRE, indicative of bacteriostatic behavior on the part of these compounds. Viewed as a whole, these observations suggest that the quaternary and nonquaternary compounds may exert their antibacterial properties through differing mechanisms of action.
To further explore the mechanistic differences between the quaternary and nonquaternary compounds with regard to their antibacterial activities, the impacts of 4b, 5b, 11a, 12a, 14, and 18 on the self-polymerization of purified S. aureus FtsZ (SaFtsZ) were evaluated using a previously established microtiter platebased light-scattering assay. [24] [25] [26] [27] [28] In this assay, FtsZ polymerization is detected in solution by a time-dependent increase in light scattering, as reflected by a corresponding increase in solution absorbance at 340 nm (A 340 ). Figure 1 shows the time-dependent A 340 profiles of SaFtsZ in the presence of DMSO vehicle alone or 4b, 5b, 11a, 12a, 14, or 18. Note that the nonquaternary compounds 11a, 12a, 14, and 18 stimulate SaFtsZ polymerization ( Fig. 1A and  B) . We next explored the stability of the SaFtsZ polymers induced by the nonquaternary compounds. In the absence of a polymer-stabilizing agent or compound, addition of GDP has been shown to depolymerize FtsZ polymers formed in the presence of GTP. 16 We examined the impact, if any, of added GDP (10 mM) on the SaFtsZ polymers formed in the presence of both GTP (1 mM) and the compounds (40 lg/mL).
The addition of 10 mM GDP did not exert a significant impact on the A 340 signal, an observation indicating that SaFtsZ polymers induced by the presence of the compounds are stable to the depolymerizing effects of GDP. These collective results are consistent with the bactericidal activities of the non-quaternary quinoxaline, 36 MIC is defined as the lowest compound concentration at which bacterial growth is P90% inhibited. quinazoline, and 1,5-naphthyridine compounds being associated with their disruptive effects on FtsZ function. In marked contrast to 11a, 12a, 14, and 18, the quaternary quinoxaline derivatives 4b and 5b exert no significant impact on SaFtsZ polymerization (Fig. 1) . This observation suggests that the bacteriostatic activities of the quaternary quinoxalines may reflect a mechanism of action unrelated to FtsZ disruption. It is possible that the quaternary compounds may disrupt the bacterial membrane, which, like the basic peptidic drugs polymyxin B and colistin, can result in bacteriostatic behavior. 
